Bacil Pharma informs about quarterly statement on investor complaints

19 Oct 2016

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Bacil Pharma Ltd. Links:

Bacil Pharma Share Price

4.15 0.19 (4.80%) Apr 15, 12:37
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 632.80
Dr. Reddys Lab 4832.45
Lupin 1042.00
Piramal Enterprises 1684.05
Cadila Healthcare 496.75
View more..
Sensex vs Bacil Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback